liposomes dr. aws alshamsan department of pharmaceutics office: aa87 tel: 4677363...

31
Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 [email protected]

Upload: deborah-may

Post on 03-Jan-2016

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposomes

Dr. Aws AlshamsanDepartment of Pharmaceutics

Office: AA87Tel: 4677363

[email protected]

Page 2: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposomes

• Spherical vesicles whose walls consist of hydrated bilayers of phospholipids

Page 3: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Phospholipids

Polar Head Groups

Three carbon glycerol

Page 4: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Phosphatidylcholines

Page 5: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Cholesterol

Page 6: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa
Page 7: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposomes Preparation

Page 8: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposomes Preparation

Page 9: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposomal structures

• SUV: Small unilamellar vesicle

• LUV: Large unilamellar vesicle

• MLV: Multilamellar vesicle

Page 10: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposome size

• Unilamellar liposomes are vesicles enclosed by a 6 to 7 nm thick single phospholipid bilayer. They range in size from 20 to 1000 nm according to the method of preparation.

• The small unilamellar vesicle [SUV] size range is 0.02 -0.05 μm, the large unilamellar vesicles [LUV] size range is greater than 0.06 μm .

Page 11: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposome size

• Multilamellar liposomes consist of concentric phospholipid bilayers separated by aqueous layers of 2.8 nm thickness.

• The multilamellar vesicle [MLV] size range is 0.1 – 0.5 µm

Page 12: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Drug loading

Page 13: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Drug loading

1.Encapsulation:The physicochemical properties of the drug itself, especially solubility and partition coefficient, are important determinant of the extent of its incorporation in liposomes. It is useful for water-soluble drugs, the encapsulation is simple hydration of a lipid with an aqueous solution of drug. The formation of liposomes passively entraps dissolved drug in the interlamellar spaces, essentially encapsulating a small volume.

Page 14: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Drug loading

2. Partitioning:A drug substance that is soluble in organic solvents will go through partitioning. It is dissolve along with phospholipid in a suitable organic solvent. This combination is dried first after that added directly to the aqueous phase and solvent residues remove under vacuum. The acyl chains of the phospholipids provide a solubilizing environment for the drug molecule. This will be located in the intrabilayer space.

Page 15: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Drug loading

3. Reverse loading:The reverse-loading mechanism uses for certain drugs may exist in both charged and uncharged forms depending on the pH of the environment. This type of drug can be added to an aqueous phase in the uncharged state to permeate into liposomes through their lipid bilayers. Then the internal pH of the liposome is adjusted to create a charge on the drug molecules. Once, charged the drug molecules no longer is lipophilic enough to pass through the lipid bilayer and return to the external medium.

Page 16: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposome classes

Page 17: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

PEG-Liposomes

Page 18: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

PEG-Liposomes

Page 19: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

PEG-Liposomes

Page 20: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

20

PEG-Liposomes• Easily uptaken by macrophages• Overcome by Stealth property (PEGylation)

Page 21: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Phosphatidylethanolamine

Page 22: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Immunoliposomes

Page 23: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Advantages of Liposomes

• 1. Liposomes are biocompatible, completely biodegradable, non-toxic, flexible and nonimmunogenic for systemic and non-systemic administrations.

• 2. Liposomes supply both a lipophilic environment and aqueous “milieu interne” in one system and are therefore suitable for delivery of hydrophobic, amphipathic and hydrophilic drugs and agents.

Page 24: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Advantages of Liposomes

• 3. Liposomes have the ability to protect their encapsulated drug from the external environment and to act as sustained release depots.

• 4. Liposomes can be formulated as a suspension, as an aerosol, or in a semisolid form such as gel, cream and lotion, as a dry vesicular powder for reconstitution or they can be administered through most routes of administration including ocular, pulmonary, nasal, oral, intramuscular, subcutaneous, topical and intravenous.

Page 25: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Advantages of Liposomes

• 5. Liposomes could encapsulate not only small molecules but also macromolecules DNA and proteins.

• 6. Liposomes are reduced toxicity and increased stability of entrapped drug via encapsulation.

• 7. Liposomes are increased efficacy and therapeutic index of drugs.

Page 26: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Advantages of Liposomes

• 8. Liposomes help to reduce exposure of sensitive tissues to toxic drugs.

• 9. Alter the pharmacokinetic property of drugs (reduced elimination, increased circulation life time)

• 10. Flexibility to couple with site-specific ligands to achieve active targeting.

Page 27: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Disadvantages of Liposomes• 1. Production cost is high

• 2. Leakage and fusion of encapsulated drug / molecules.

• 3. Sometimes phospholipid undergoes oxidation and hydrolysis reaction

• 4. Short half-life

• 5. Low solubility

• 6. Instability

Page 28: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Evolution of liposomes

Page 29: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Liposomes interaction with cells

Page 30: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa
Page 31: Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa

Hand-foot syndrome

• Palmar-plantar erythrodysesthesia (PPE), also called hand-to-foot syndrome